32.97
-0.97(-2.86%)
Currency In USD
| Previous Close | 33.94 |
| Open | 33.52 |
| Day High | 34.02 |
| Day Low | 32.61 |
| 52-Week High | 103.81 |
| 52-Week Low | 32.11 |
| Volume | 898,201 |
| Average Volume | 1.19M |
| Market Cap | 1.83B |
| PE | -21.41 |
| EPS | -1.54 |
| Moving Average 50 Days | 37.69 |
| Moving Average 200 Days | 55.25 |
| Change | -0.97 |
If you invested $1000 in PROCEPT BioRobotics Corporation (PRCT) since IPO date, it would be worth $786.12 as of October 19, 2025 at a share price of $32.97. Whereas If you bought $1000 worth of PROCEPT BioRobotics Corporation (PRCT) shares 3 years ago, it would be worth $801.41 as of October 19, 2025 at a share price of $32.97.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
PROCEPT BioRobotics® to Report Third Quarter 2025 Financial Results on November 4, 2025
GlobeNewswire Inc.
Oct 15, 2025 8:03 PM GMT
SAN JOSE, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it
PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO
GlobeNewswire Inc.
Jul 24, 2025 10:00 PM GMT
Larry L. Wood to join PROCEPT BioRobotics effective September 2, 2025Company confirms strong underlying business trends and pre-announces 2Q25 revenue of approximately $79.2 million, representing annual growth of 48% SAN JOSE, Calif., July 24, 2025
Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy
GlobeNewswire Inc.
Jul 23, 2025 12:00 PM GMT
SAN JOSE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through transformative urology solutions, today announced that thre